NASDAQ$IRTC
IRhythm Holdings Inc · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
iRhythm's financial performance increased in revenue but faced challenges with gross margin due to reimbursement rate reductions and COVID-19 impacts.
iRhythm Technologies reported a 17% increase in revenue to $74.3 million for the first quarter of 2021, driven by Zio XT volume and Zio AT expansion. However, the gross margin decreased to 68.4% due to reduced Medicare reimbursement rates and COVID-19 pandemic related costs. The company is actively pursuing multiple paths to achieve better reimbursement rates and focusing on efficiency improvements.
- Revenue increased by 17% to $74.3 million compared to Q1 2020.
- Gross margin decreased to 68.4% from 74.7% in the same period last year.
- Adjusted EBITDA was negative $5.2 million, an increase of $2.2 million compared to Q1 2020.
- Cash and Short-Term Investments were $262 million as of March 31, 2021.
Headline financials
Revenue & EPS history
iRhythm · Revenue · Quarterly
$74.3M
Forward guidance
For the second quarter 2021, iRhythm expects sequential volume growth of approximately 4% over the first quarter of 2021 and OPEX to be approximately flat to first quarter 2021 with reductions in stock-based compensation and payroll taxes offset by increases in legal and consulting spending and hiring to support investments.
Tailwinds
- Expects sequential volume growth of approximately 4% over the first quarter of 2021
- OPEX to be approximately flat to first quarter 2021
- Reductions in stock-based compensation
- Reductions in payroll taxes
- Hiring to support investments.
Headwinds
- Increases in legal and consulting spending.
- Pursuing multiple paths to achieve pricing that is more in line with the benefits of its technology.
- Engaging with Novitas to better understand their valuation methodology
- Having discussions with other Medicare Administrative Contractors (MACs)
- Continuing to pursue national pricing with the Centers for Medicare and Medicaid Services (CMS).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
+1.6%
Avg return
Earnings day
-0.4%
Avg return
5 days after
-0.7%
Avg return
30 days after
50%
19 / 38 earnings
Positive
+20.4%
Q1 2025
Best reaction
-14.3%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.9% | -8.9% | -11.8% | |
| Q4 2025 | -4.6% | -14.5% | -26.8% | |
| Q3 2025 | +0.6% | -2.0% | +2.1% | |
| Q1 2025 | +20.4% | +25.4% | +29.4% | |
| Q4 2024 | +6.0% | -2.9% | -7.3% | |
| Q3 2024 | -1.8% | -13.9% | +4.0% | |
| Q2 2024 | -14.3% | -15.6% | -17.8% | |
| Q1 2024 | -0.4% | -3.7% | -5.5% | |
| Q4 2023 | -5.3% | -1.7% | +10.2% | |
| Q3 2023 | -2.3% | -11.1% | -18.5% | |
| Q2 2023 | +13.9% | +10.7% | +1.2% | |
| Q1 2023 | -6.2% | -6.4% | -20.6% | |
| Q4 2022 | +8.2% | +9.2% | +12.5% | |
| Q3 2022 | -5.0% | -19.3% | -15.0% | |
| Q2 2022 | -3.3% | -8.4% | -1.1% | |
| Q1 2022 | -3.7% | +2.5% | +10.6% | |
| Q4 2021 | +13.2% | +16.1% | +29.1% | |
| Q3 2021 | -14.1% | -15.6% | -19.7% | |
| Q2 2021 | +0.7% | -3.6% | -4.7% | |
| Q1 2021 | +6.9% | +2.8% | -17.0% | |
| Q4 2020 | +5.2% | -2.7% | -10.9% | |
| Q3 2020 | +13.1% | +11.1% | -20.0% | |
| Q2 2020 | +6.3% | -4.4% | +11.8% | |
| Q1 2020 | +13.3% | +14.8% | +9.3% | |
| Q4 2019 | +9.7% | +10.1% | -13.8% | |
| Q3 2019 | +11.5% | +8.3% | +41.1% | |
| Q2 2019 | +3.4% | +7.8% | +1.2% | |
| Q1 2019 | -5.0% | -1.6% | +1.6% | |
| Q4 2018 | -2.2% | -9.4% | -25.7% | |
| Q3 2018 | +1.0% | +7.6% | -3.0% | |
| Q2 2018 | -1.8% | -3.8% | +9.5% | |
| Q1 2018 | -0.9% | -1.3% | +15.7% | |
| Q4 2017 | +3.3% | +4.1% | +1.3% | |
| Q3 2017 | +5.8% | +11.7% | +6.6% | |
| Q2 2017 | -0.1% | +0.4% | +9.3% | |
| Q1 2017 | -0.5% | -0.1% | +7.4% | |
| Q4 2016 | +2.0% | +1.9% | -3.0% | |
| Q3 2016 | -5.1% | -7.7% | +2.5% | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro